Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They've filed 8Ks in 2016 and 2019 with material info.
If they had awarded themselves more preferred shares that's material info they need to report in an 8K like they did in 2015.
I'm going by the 8Ks filed on Edgar
Rene. Mark, Todd and to a lesser extent Paul own a combined 1,587,145 Series C preferred shares
Convertible into common at a 1:350 ratio
1:350 ratio
Rene. Mark, Todd and to a lesser extent Paul own a combined 1,587,145 Series C preferred shares
google "ihub aryc letter to shareholders"
FYI. Moss Krusick issued an audit report on the Company’s financial statements as of and for the years ended December 31, 2013 and December 31, 2014. 2014 needed to be re-audited by RRBB because of Moss' troubles.
If it gets to this, the company can defend itself either in court or in SEC proceeding.
They can sell their covid-19 test right now, and they are doing so. The FDA does not object.
The allergy test is not impacted. Two separate tests. IMO How Arrayit wants to market them, together or separate is up to them.
According to https://antibodycovidtest.com/
it seems that as encouraged by the FDA they did apply for EUA for the covid test, and are waiting for the authorization. An authorization will give it more credibility still.
I agree. Why couldn't the company issue a statement clarifying the whole state of affairs instead of us having to piece it together from the media, people looking at the FDA website, the LA outfit, etc?
No problem :)
This seems to indicate that Arrayit although not required, but encouraged, to obtain EUA did apply for EUA.
Don't feel bad. The FDA guidelines for the covid-19 antibodies tests have been confusing. There are now 179 manufacturers and 20 high complexity labs selling tests in what some people have called a "wild west" of tests.
The FDA has been criticized for allowing tests that are not even accurate to be sold. Doctors are confused as to which tests are good. That's why the FDA continues to fine tune the guidelines.
Arrayit fits in the lab the category below. They are not required to get Emergency Use Authorization (EAU) but they are encouraged to do so.:
Pennsy you say: interesting "to see if Mark has the persistence to actually see the 10 day period through to completion".
The 10 day applies to manufacturers only, not to CLIA high complexity laboratories like Arrayit.
Arrayit has an active CLIA certificate -Thanks for sharing BeckElliot
And who made that statement? Not the company.
Roche said "its antibody test has a specificity rate exceeding 99.8% and sensitivity of 100%, meaning tests would show very few false positives and no false negatives."
But like you said, they use blood from a vein.
Thanks to Scorpgirl. She's the one who found out this website with the current labs
And the In-State Laboratories Map "Page Last Updated : April 29, 2020"
which is after the alleged 4/18 expiration.
Thanks for sharing.
Page Last Updated : April 29, 2020
So high complexity CLIA labs like Arrayit's are not required to get EUA to sell their tests, although they are encouraged to do so.
https://www.washingtonpost.com/health/2020/05/04/fda-steps-up-scrutiny-coronavirus-antibody-tests-ensure-accuracy/
Another wrinkle on EUA - favorable to ARYC since Arrayit is in the "two dozen" labs group.
Did you ask them if they have received data from Arrayit proving the accuracy of its test?
So these labs, including Arrayit, have notified the FDA that they have validated and are offering serology tests. "The FDA has not yet reviewed the laboratory's validation and issued an EUA for the laboratory's test"
Now the FDA is telling the labs selling coronavirus antibody tests "to submit data proving accuracy within the next 10 days or face removal from the market."
10 days to do or die.
Thanks for sharing the breaking news. Nobody knew about it until you posted it.
Whatever happened to the other FDA approval for another test that Mark was working on 2 years ago:
Arrayit provides 7/2/18 FDA update: (1) excellent meeting, (2) large attendance by FDA top brass, (3) insightful and instructive, (4) our entire clinical team wishes to thank the agency for their feedback and generosity, and (5) we believe that our test will receive FDA approval. pic.twitter.com/KPkURL4Mxy
— Arrayit Corporation (@arrayit) July 3, 2018
Sunnyvale, July 01, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, has been approved to receive electronic Medicare payments for its allergy testing healthcare services from the Centers for Medicare and Medicaid Services (CMS). As a Medicare-enrolled CMS healthcare provider,
Sunnyvale, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC), a life sciences and personalized medicine company, has been approved by a leading Medicare Administrative Contractor (MAC) on behalf of the Centers for Medicare and Medicaid Services (CMS) as a new allergy testing services healthcare provider for Medicare Part B
Actually, PSA is pricing the allergy test orders @ $10,000 each.
The SEC has no problem with the allergy test.
The second test is the covid-19 component.
What claims did they make?
So why did the SEC mention the lack of fins since 2015 in the suspension order?
P.S I'm not going to get into the back and forth about the form 15 that they filed just suspending reporting, not deregistering
IMO even if they trade in the grey market they still have to file per SEC reguations.
Whatever you choose to believe.
Form 15 can be used to de-register and also to suspend reporting.
It has several boxes to check and you choose what you are applying for.
Arrayit only chose the box to suspend reporting and not the boxes to de-register.